Schear Investment Advisers LLC Sells 7,227 Shares of GE HealthCare Technologies Inc. $GEHC

Schear Investment Advisers LLC lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 49.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,412 shares of the company’s stock after selling 7,227 shares during the period. Schear Investment Advisers LLC’s holdings in GE HealthCare Technologies were worth $608,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Dodge & Cox boosted its holdings in shares of GE HealthCare Technologies by 16.8% during the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after purchasing an additional 3,949,361 shares during the last quarter. Capital Research Global Investors raised its position in shares of GE HealthCare Technologies by 25.0% during the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after buying an additional 4,998,154 shares in the last quarter. Hotchkis & Wiley Capital Management LLC raised its position in shares of GE HealthCare Technologies by 17.1% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock valued at $633,271,000 after buying an additional 1,232,828 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of GE HealthCare Technologies by 8.9% during the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company’s stock valued at $402,647,000 after buying an additional 438,439 shares in the last quarter. Finally, Van ECK Associates Corp raised its position in shares of GE HealthCare Technologies by 3.2% during the 3rd quarter. Van ECK Associates Corp now owns 4,497,827 shares of the company’s stock valued at $337,787,000 after buying an additional 139,404 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of several recent research reports. Barclays upped their target price on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Morgan Stanley upped their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. BTIG Research restated a “buy” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research report on Tuesday. Finally, Citigroup decreased their target price on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research report on Wednesday, March 11th. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Hold” and a consensus price target of $89.77.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $71.38 on Thursday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies Inc. has a 1-year low of $64.28 and a 1-year high of $89.77. The firm has a market capitalization of $32.57 billion, a P/E ratio of 15.65, a price-to-earnings-growth ratio of 1.59 and a beta of 1.17. The company’s 50-day moving average is $75.05 and its 200 day moving average is $77.88.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts forecast that GE HealthCare Technologies Inc. will post 5 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.